Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N G Samsonova

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Terapevticheskii Arkhiv|March 11, 2008
[Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment]L B Lazebnik, O N Ovsiannikova, L A Zvenigorodskaia, et al.
Terapevticheskii Arkhiv|February 1, 2019
Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practiceO V Knyazev, A V Kagramanova, A A Lishchinskaya, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Terapevticheskii Arkhiv|March 11, 2008
[Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment]L B Lazebnik, O N Ovsiannikova, L A Zvenigorodskaia, et al.
Terapevticheskii Arkhiv|February 1, 2019
Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practiceO V Knyazev, A V Kagramanova, A A Lishchinskaya, et al.
Pageof 2